A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
GlobalData on MSN5d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective hoisted by research analysts at Stifel Nicolaus from ...
Medical Xpress on MSN10d
Spinal cord electrical stimulation restores neural function in clinical trialAn intervention, which involves electrical stimulation of the sensory spinal nerves, can gradually reawaken functionally ...
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...
In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.
Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback